Allient (ALNT) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved record gross margin of 33.2% in Q2 2025, with strong profitability, robust cash generation, and operational execution across key markets, supported by strategic initiatives and cost reduction programs.
Revenue reached $139.6M, up 5% sequentially and 3% year-over-year, driven by demand in data center infrastructure, defense, and select medical applications, with favorable FX impact.
Net income rose to $5.6M ($0.34 per diluted share), up 388% year-over-year; adjusted net income was $9.5M ($0.57 per share), with adjusted EBITDA at $20.1M (14.4% of revenue).
Operational initiatives, including the Simplify to Accelerate Now program and Dothan restructuring, are delivering targeted $6–$7M in annualized savings.
Record operating cash flow of $24.5M, up 76% sequentially and nearly 3x year-over-year, with net debt reduced by $35.8M YTD and leverage ratio down to 2.3x.
Financial highlights
Q2 2025 revenue was $139.6M, up 3% year-over-year and 5% sequentially, with a $2.4M FX benefit.
Gross margin reached a record 33.2%, up 330 bps year-over-year and 100 bps sequentially.
Operating income more than doubled to $11.7M; operating margin rose to 8.4%, up 480 bps year-over-year.
Adjusted EBITDA was $20.1M (14.4% of revenue), up 420 bps year-over-year.
Cash and cash equivalents increased to $49.9M as of June 30, 2025.
Outlook and guidance
Q3 sales expected to be sequentially lower due to $3–$4M in revenue pulled into Q2; near-term revenue cadence may reflect timing shifts and seasonal patterns, especially in Europe.
Full-year 2025 effective tax rate expected to be 21%–23%.
Capital expenditures for 2025 projected at $8–$10M.
Confident in delivering sustainable, high-quality growth despite near-term volatility.
Company expects to realize $6–$7M in annualized cost savings from ongoing restructuring.
Latest events from Allient
- Record 2025 revenue growth, margin expansion, and deleveraging support a strong 2026 outlook.ALNT
Q4 20256 Mar 2026 - Q2 revenue down 7% to $136M; $10M in cost savings targeted amid market softness.ALNT
Q2 20242 Feb 2026 - Revenue dropped 14% but margin gains and cost savings supported strong cash flow.ALNT
Q3 202415 Jan 2026 - Q4 margin expansion and order growth offset revenue softness, with cost savings driving 2025 outlook.ALNT
Q4 20242 Dec 2025 - Annual meeting covers director elections, executive pay, auditor ratification, and ESG oversight.ALNT
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor ratification for 2025.ALNT
Proxy Filing2 Dec 2025 - Sequential sales and margin growth offset year-over-year revenue decline; orders surged.ALNT
Q1 202526 Nov 2025 - Q3 2025 saw 11% revenue growth, record margin, and strong cash flow with lower net debt.ALNT
Q3 202513 Nov 2025